Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Current non-invasive approaches for detection of urothelial cancers are suboptimal. We
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
[HTML][HTML] Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
J Cole, D Ertoy, H Lin, RL Sutliff, E Ezan… - The Journal of …, 2000 - Am Soc Clin Investig
While nephrologists often observe reduced hematocrit associated with inhibitors of
angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We …
angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We …
PAX8 (+)/p63 (−) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial …
R Albadine, L Schultz, P Illei, D Ertoy… - The American journal …, 2010 - journals.lww.com
Background Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal
malignancy with variable morphologic features. One of the World Health Organization …
malignancy with variable morphologic features. One of the World Health Organization …
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey
Transcription factor E3-rearranged renal cell carcinoma (TFE3-RCC) has heterogenous
morphologic and immunohistochemical (IHC) features. 131 pathologists with genitourinary …
morphologic and immunohistochemical (IHC) features. 131 pathologists with genitourinary …
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
Noninvasive approaches for early detection of bladder cancer are actively being
investigated. We recently developed a urine-based molecular assay for the detection and …
investigated. We recently developed a urine-based molecular assay for the detection and …
High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma
Somatic activating mutations in the promoter of the telomerase reverse transcriptase (TERT)
gene are the most common genetic alterations in urothelial carcinoma (UC) of the bladder …
gene are the most common genetic alterations in urothelial carcinoma (UC) of the bladder …
Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations
Activating mutations in the promoter of the telomerase reverse transcriptase (TERT) gene
are the most common genetic alterations in urothelial carcinoma (UC) of the bladder and …
are the most common genetic alterations in urothelial carcinoma (UC) of the bladder and …
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
…, A Kurne, C Bilen, H Ozen, D Ertoy… - Journal of Neurology …, 2008 - jnnp.bmj.com
Discussion These findings expand our current understanding of autoimmune encephalitis in
several aspects. To our knowledge, this is the first case of teratoma-related anti-NMDA …
several aspects. To our knowledge, this is the first case of teratoma-related anti-NMDA …
[HTML][HTML] High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder
TERT promoter mutations (TERT-mut) are detectable in the majority of urothelial
carcinomas. The detection of TERT-mut in urine is under investigation as a potential urine …
carcinomas. The detection of TERT-mut in urine is under investigation as a potential urine …
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
Our group and others have previously demonstrated the presence of TERT promoter
mutations (TERT-mut) in 60–80% of urothelial carcinomas and some of their histologic …
mutations (TERT-mut) in 60–80% of urothelial carcinomas and some of their histologic …